EPISODE · May 6, 2025 · 10 MIN

Inebilizumab Trial in Myasthenia Gravis

from Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology · host Amer Ghavanini

Published in New England Journal of Medicine the study details the MINT trial, a phase 3 clinical trial evaluating the efficacy and safety of inebilizumab for treating generalized myasthenia gravis (MG). #Neurology #Myasthenia

Episode metadata supplied by the publisher feed · Published May 6, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Inebilizumab Trial in Myasthenia Gravis

0:00 10:09

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology?

This episode is 10 minutes long.

When was this Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology episode published?

This episode was published on May 6, 2025.

Can I download this Weekly Neurology Deep Dive - A review of recent impactful publications in the field of Neurology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!